159 related articles for article (PubMed ID: 7904604)
1. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
[TBL] [Abstract][Full Text] [Related]
2. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
3. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
[TBL] [Abstract][Full Text] [Related]
4. In vitro transcriptional studies of the roles of the thyroid hormone (T3) response elements and minimal promoters in T3-stimulated gene transcription.
Suen CS; Yen PM; Chin WW
J Biol Chem; 1994 Jan; 269(2):1314-22. PubMed ID: 8288596
[TBL] [Abstract][Full Text] [Related]
5. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
6. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
7. Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers.
Yen PM; Darling DS; Carter RL; Forgione M; Umeda PK; Chin WW
J Biol Chem; 1992 Feb; 267(6):3565-8. PubMed ID: 1740410
[TBL] [Abstract][Full Text] [Related]
8. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes.
Katz D; Lazar MA
J Biol Chem; 1993 Oct; 268(28):20904-10. PubMed ID: 8407924
[TBL] [Abstract][Full Text] [Related]
10. Roles of 3,5,3'-triiodothyronine and deoxyribonucleic acid binding on thyroid hormone receptor complex formation.
Yen PM; Brubaker JH; Apriletti JW; Baxter JD; Chin WW
Endocrinology; 1994 Mar; 134(3):1075-81. PubMed ID: 8119145
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
Bigler J; Hokanson W; Eisenman RN
Mol Cell Biol; 1992 May; 12(5):2406-17. PubMed ID: 1314955
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements.
Ikeda M; Rhee M; Chin WW
Endocrinology; 1994 Oct; 135(4):1628-38. PubMed ID: 7925126
[TBL] [Abstract][Full Text] [Related]
15. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between thyroid hormone and specific retinoid X receptor subtypes in yeast selectively regulates cognate ligand actions.
Walfish PG; Yang YF; Ypganathan T; Chang LA; Butt TR
Gene Expr; 1996; 6(3):169-84. PubMed ID: 9041123
[TBL] [Abstract][Full Text] [Related]
17. Homodimer and heterodimer DNA binding and transcriptional responsiveness to triiodothyronine (T3) and 9-cis-retinoic acid are determined by the number and order of high affinity half-sites in a T3 response element.
Force WR; Tillman JB; Sprung CN; Spindler SR
J Biol Chem; 1994 Mar; 269(12):8863-71. PubMed ID: 8132622
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
Downes M; Carozzi AJ; Muscat GE
Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
[TBL] [Abstract][Full Text] [Related]
19. The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA-binding and heterodimerization properties.
Katz D; Berrodin TJ; Lazar MA
Mol Endocrinol; 1992 May; 6(5):805-14. PubMed ID: 1318505
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
